CD40LG and metastatic melanoma: In conclusion, by analyzing the CDR3 output of circulating memory B cells derived from patients with metastatic melanoma, we present findings indicating a specific enrichment of IgG and IgM type antibodies, present in patients’ blood exclusively after nivolumab therapy.